TSO3 Inc (TOS)-医療機器分野:企業M&A・提携分析

◆英語タイトル:TSO3 Inc (TOS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011946
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TSO3 Inc (TSO3) is a medical device company that designs develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The company’s flagship product is Sterizone VP4 Sterilizer, a dual sterilant, low-temperature sterilization system, which utilizes vaporized hydrogen peroxide and ozone. The company’s product is based on its patented Sterizone sterilization platform. The company also offers services such as maintenance of sterilization equipment and compatibility testing of medical devices. The product finds use in hospitals and clinical settings with high patient turnover. TSO3 is headquartered in Quebec, Canada.

TSO3 Inc (TOS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TSO3 Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
TSO3 Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
TSO3 Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
TSO3 Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
TSO3 Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
TSO3 Inc, Medical Equipment, Deal Details 10
Partnerships 10
Getinge Infection Control Enters into Distribution Agreement with TSO3 10
TSO3 Amends Distribution Agreement With 3M 11
Equity Offering 12
Tso3 Raises USD9 Million in Public Offering of Units 12
Tso3 Completes Public Offering Of Shares For US$6.9 Million 13
TSO3 Completes Private Placement Of Units For US$9 Million 14
TSO3 Inc – Key Competitors 15
TSO3 Inc – Key Employees 16
TSO3 Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 06, 2017: TSO3 Reports Record Third Quarter 2017 Results 18
Aug 01, 2017: TSO3 Reports Record Second Quarter 2017 Results 19
May 10, 2017: TSO3 Reports Record First Quarter 2017 Results 20
Mar 21, 2017: TSO3 Reports Record Fourth Quarter and Full Year 2016 Results 22
Nov 07, 2016: TSO3 Reports Third Quarter 2016 Results 24
Aug 03, 2016: TSO3 Reports Second Quarter 2016 Results 25
May 04, 2016: TSO3 Reports Record First Quarter 2016 Results 27
Mar 23, 2016: TSO3 Reports Fourth Quarter and Full Year 2015 Results 28
Corporate Communications 30
Sep 25, 2017: TSO3 Appoints Dr. Bradley J. Catalone as Chief Science Officer 30
Feb 16, 2017: TSO3 Appoints Dr. Linda Rosenstock and Mr. Jeffrey Pompeo to its Board of Directors 31
Feb 02, 2017: TSO3 Appoints Mark Pasmore as Vice President of Research and Development 32
Jan 27, 2016: TSO3 Appoints Harold R. Tessman as COO 33
Product News 34
02/25/2016: TSO3 Provides Operations Update – Recruiting, Supplier Relationships and Improved Process Flow All Contributing to Increased Production Rates and Shipments 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
TSO3 Inc, Medical Equipment, Key Facts, 2015 2
TSO3 Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
TSO3 Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
TSO3 Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
TSO3 Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
TSO3 Inc, Deals By Market, 2011 to YTD 2017 8
TSO3 Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Getinge Infection Control Enters into Distribution Agreement with TSO3 10
TSO3 Amends Distribution Agreement With 3M 11
Tso3 Raises USD9 Million in Public Offering of Units 12
Tso3 Completes Public Offering Of Shares For US$6.9 Million 13
TSO3 Completes Private Placement Of Units For US$9 Million 14
TSO3 Inc, Key Competitors 15
TSO3 Inc, Key Employees 16
TSO3 Inc, Subsidiaries 17

★海外企業調査レポート[TSO3 Inc (TOS)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mitsubishi Chemical Corp:企業の戦略的SWOT分析
    Mitsubishi Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Diffusion Pharmaceuticals Inc (DFFN)-製薬・医療分野:企業M&A・提携分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a drug development company that develops standard-of-care therapies. The company offers new and small-molecule drugs for regulating the movement of oxygen into tissue. It provides therapeutic for life-threat …
  • PDS Biotechnology Corp-製薬・医療分野:企業M&A・提携分析
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops immunotherapies and vaccines for cancer and infectious disease. The company uses versamune technology, which is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothe …
  • Mitsubishi Heavy Industries Ltd (7011)-エネルギー分野:企業M&A・提携分析
    Summary Mitsubishi Heavy Industries Ltd (MHI) is a manufacturer of heavy machinery. It offers a diverse range of products and services for power plants, chemical plants, environmental equipment, steel structures, industrial and general machinery, shipbuilding, aircraft, space systems and air-conditi …
  • SACI Falabella:企業の戦略・SWOT・財務情報
    SACI Falabella - Strategy, SWOT and Corporate Finance Report Summary SACI Falabella - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Zelan Bhd:企業の戦略・SWOT・財務情報
    Zelan Bhd - Strategy, SWOT and Corporate Finance Report Summary Zelan Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • McAfee, Inc.:企業の戦略的SWOT分析
    McAfee, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Catabasis Pharmaceuticals Inc (CATB):企業の財務・戦略的SWOT分析
    Summary Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and ratio …
  • Lonestar Resources US Inc (LONE):石油・ガス:M&Aディール及び事業提携情報
    Summary Lonestar Resources US Inc (Lonestar) is an independent oil and gas company that focuses on acquisition, exploration, development and production of oil and natural gas resources. Lonestar holds majority of the working interests in its properties and manages activities related to designing and …
  • Orvana Minerals Corporation:企業の戦略・SWOT・財務情報
    Orvana Minerals Corporation - Strategy, SWOT and Corporate Finance Report Summary Orvana Minerals Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Clark Enterprises Inc:企業の戦略・SWOT・財務情報
    Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • BCE Inc.:戦略・SWOT・企業財務分析
    BCE Inc. - Strategy, SWOT and Corporate Finance Report Summary BCE Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Samba Private Banking:企業の戦略・SWOT・財務分析
    Samba Private Banking - Strategy, SWOT and Corporate Finance Report Summary Samba Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ILF Consulting Engineers:企業の戦略・SWOT・財務情報
    ILF Consulting Engineers - Strategy, SWOT and Corporate Finance Report Summary ILF Consulting Engineers - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • United States Steel Corp (X):企業の財務・戦略的SWOT分析
    United States Steel Corp (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Redbiotec AG-製薬・医療分野:企業M&A・提携分析
    Summary Redbiotec AG (Redbiotec) is a biopharmaceutical company that develops prophylactic vaccines, which target various virus associated diseases. The company produces multi component virus like particles and other protein assemblies through its rePAX coexpression technology. It is developing prod …
  • Mitobridge Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Mitobridge Inc (Mitobridge), formerly Mitokyne Inc, a subsidiary of Astellas Pharma Inc is a drug development company that discovers and develops small molecule therapeutics that recovers mitochondrial functions. The company develops therapies for rare diseases and expands into more common d …
  • Webjet Limited:企業の戦略・SWOT・財務情報
    Webjet Limited - Strategy, SWOT and Corporate Finance Report Summary Webjet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Illinois Municipal Electric Agency:企業の戦略的SWOT分析
    Illinois Municipal Electric Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Aker Solutions ASA:企業のM&A・事業提携・投資動向
    Aker Solutions ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aker Solutions ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆